Arcturus Therapeutics (ARCT) Q2 2026 Earnings

7MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-1.18
-0.9
-0.62
-0.34

Details

Expected EPS
-1.009936
Actual EPS
-0.95
Surprise EPS
0.06
Surprise Percent
+5.93%

Description

Arcturus Therapeutics (ARCT) has reported earnings of -0.95 per share for Q2 2026.

0 Comments

Share your thoughts